Haraguchi Y, Sakamoto A, Yoshida T, Tanaka K
First Department of Internal Medicine, Miyazaki Medical College, Japan.
Gastroenterol Jpn. 1988 Jun;23(3):247-50. doi: 10.1007/BF02779466.
Gastrin releasing peptide(GRP)-like immunoreactivity in human plasma was measured using radioimmunoassay of neuromedin C (NMC) in 83 healthy and 58 diseased subjects. In the healthy group, the mean value of fasting GRP-like immunoreactivity was 2.1 +/- 1.4 (mean +/- SD) pmol/L. There was a slight positive correlation between the GRP-like immunoreactivity values and aging. Postprandial serial measurements demonstrated that GRP-like immunoreactivity showed no response to a significant elevation of serum gastrin concentration. The group with chronic renal failure on hemodialysis gave the highest value, 7.1 +/- 2.1 pmol/L (p less than 0.01). There were no statistical differences between the healthy controls and groups with peptic ulcer, liver cirrhosis, diabetes mellitus or carcinomas, although some cancer patients had a marked increase in GRP-like immunoreactivity value.
采用对神经介素C(NMC)的放射免疫分析法,对83名健康受试者和58名患病受试者的人血浆中胃泌素释放肽(GRP)样免疫活性进行了测定。在健康组中,空腹GRP样免疫活性的平均值为2.1±1.4(平均值±标准差)pmol/L。GRP样免疫活性值与年龄之间存在轻微正相关。餐后连续测量表明,GRP样免疫活性对血清胃泌素浓度的显著升高无反应。接受血液透析的慢性肾衰竭组的值最高,为7.1±2.1 pmol/L(p<0.01)。尽管一些癌症患者的GRP样免疫活性值有明显升高,但健康对照组与消化性溃疡、肝硬化、糖尿病或癌症组之间无统计学差异。